|
EP1740615B1
(en)
*
|
2004-03-31 |
2014-11-05 |
Genentech, Inc. |
Humanized anti-tgf-beta antibodies
|
|
EP1966243B1
(en)
*
|
2005-12-23 |
2012-02-15 |
Eli Lilly And Company |
Tgf-beta binding antibodies
|
|
US8350006B2
(en)
*
|
2008-10-24 |
2013-01-08 |
Mead Johnson Nutrition Company |
Methods for determining the bioactivity of TGF-β in a composition
|
|
JP5818688B2
(ja)
*
|
2009-01-08 |
2015-11-18 |
バイオ−ラッド ラボラトリーズ インコーポレーティッド |
核酸増幅反応の効率を改善するための方法および組成物
|
|
WO2010124276A2
(en)
*
|
2009-04-24 |
2010-10-28 |
Vanderbilt Universtiy |
Anti-tgf-beta induction of bone cell function and bone growth
|
|
CN103732623B
(zh)
*
|
2011-06-03 |
2017-09-29 |
佐马技术有限公司 |
对TGF‑β具有特异性的抗体
|
|
CA2866378A1
(en)
|
2012-03-08 |
2013-09-12 |
Selig Sealing Products, Inc. |
Container sealing member with protected security component and removal tab
|
|
US9518112B2
(en)
|
2012-03-08 |
2016-12-13 |
Ludwig Institute For Cancer Research Ltd |
TGF-β1 specific antibodies and methods and uses thereof
|
|
HRP20181939T4
(hr)
*
|
2013-03-20 |
2022-05-13 |
Genzyme Corporation |
Postupci za liječenje osteogenesis imperfecta
|
|
WO2016024628A1
(ja)
*
|
2014-08-14 |
2016-02-18 |
学校法人東京医科大学 |
樹状細胞の抗癌免疫賦活能の促進方法およびその用途
|
|
WO2016115345A1
(en)
|
2015-01-14 |
2016-07-21 |
The Brigham And Women's Hospital, |
Treatment of cancer with anti-lap monoclonal antibodies
|
|
TWI733661B
(zh)
|
2015-03-04 |
2021-07-21 |
美商健臻公司 |
以高親合性、結合性及特異性結合轉化生長因子－β１的經修飾ＩｇＧ抗體
|
|
TWI726870B
(zh)
|
2015-03-04 |
2021-05-11 |
美商健臻公司 |
具有高親和性、結合性及專一性之結合轉形生長因子-β１的ｓｃＦｖ-Ｆｃ二聚體
|
|
EP3770171A1
(en)
|
2015-04-03 |
2021-01-27 |
XOMA Technology Ltd. |
Treatment of cancer using inhibitors of tgf-beta and pd-1
|
|
US10723793B2
(en)
|
2015-06-12 |
2020-07-28 |
Ludwig Institute For Cancer Research, Ltd. |
TGF-β3 specific antibodies and methods and uses thereof
|
|
AU2017268234A1
(en)
|
2016-05-17 |
2018-12-13 |
Genentech, Inc. |
Stromal gene signatures for diagnosis and use in immunotherapy
|
|
GB201610044D0
(en)
|
2016-06-08 |
2016-07-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
WO2018128939A1
(en)
|
2017-01-05 |
2018-07-12 |
Gensun Biopharma Inc. |
Checkpoint regulator antagonists
|
|
TWI832600B
(zh)
*
|
2017-01-20 |
2024-02-11 |
美商健臻公司 |
骨靶向抗體
|
|
TW201923089A
(zh)
|
2017-11-06 |
2019-06-16 |
美商建南德克公司 |
癌症之診斷及治療方法
|
|
US10597453B2
(en)
|
2018-06-29 |
2020-03-24 |
Gensun Biopharma, Inc. |
Antitumor immune checkpoint regulator antagonists
|
|
CN113613725B
(zh)
|
2018-11-05 |
2025-09-23 |
路德维格癌症研究所有限公司 |
人源化和变体TGF-β1特异性抗体及其方法和用途
|
|
EP3877053A1
(en)
|
2018-11-05 |
2021-09-15 |
Ludwig Institute for Cancer Research Ltd |
Humanized and variant tgf-beta3 specific antibodies and methods and uses thereof
|
|
CN114340735B
(zh)
|
2019-06-28 |
2024-11-12 |
璟尚生物制药公司 |
突变的TGFβ1-RII胞外域和免疫球蛋白支架组成的抗肿瘤拮抗剂
|
|
AU2020322474A1
(en)
|
2019-08-01 |
2022-03-10 |
Vaccinex,Inc. |
Combined inhibition of semaphorin-4D and TGFβ and compositions therefor
|
|
WO2021167703A1
(en)
|
2020-02-19 |
2021-08-26 |
Nammi Therapeutics, Inc. |
Formulated and/or co-formulated liposome compositions containing tgfb antagonist prodrugs useful in the treatment of cancer and methods thereof
|
|
CN113563473A
(zh)
|
2020-04-29 |
2021-10-29 |
三生国健药业（上海）股份有限公司 |
四价双特异性抗体、其制备方法和用途
|
|
US20220119513A1
(en)
*
|
2020-06-08 |
2022-04-21 |
Zoetis Services Llc |
Anti-tgfb antibodies and therapeutic uses thereof
|
|
US20240002479A1
(en)
*
|
2020-11-23 |
2024-01-04 |
The Regents Of The University Of Michigan |
Single-chain antibody against flavivirus ns1 protein
|
|
EP4251645A1
(en)
|
2020-11-25 |
2023-10-04 |
Catamaran Bio, Inc. |
Cellular therapeutics engineered with signal modulators and methods of use thereof
|
|
CN112940119B
(zh)
*
|
2021-04-26 |
2022-05-20 |
北京芳渟阳生生物科技有限公司 |
一种单克隆抗体及其与间充质干细胞外泌体的联合应用
|
|
CN115707716A
(zh)
*
|
2021-08-18 |
2023-02-21 |
丹生医药技术(上海)有限公司 |
一种TGF-β/VEGF双功能抗体融合蛋白
|
|
WO2023080900A1
(en)
|
2021-11-05 |
2023-05-11 |
Genentech, Inc. |
Methods and compositions for classifying and treating kidney cancer
|
|
CN119213034A
(zh)
|
2022-05-17 |
2024-12-27 |
苏州创胜医药集团有限公司 |
双功能蛋白质及其制剂和用途
|
|
WO2024077095A1
(en)
|
2022-10-05 |
2024-04-11 |
Genentech, Inc. |
Methods and compositions for classifying and treating bladder cancer
|
|
EP4599088A1
(en)
|
2022-10-05 |
2025-08-13 |
Genentech, Inc. |
Methods and compositions for classifying and treating lung cancer
|
|
TW202434643A
(zh)
*
|
2023-01-09 |
2024-09-01 |
大陸商北京拓界生物醫藥科技有限公司 |
ＴＧＦβ１結合分子、ＧＡＲＰ－ＴＧＦβ１結合分子及其醫藥用途
|